eISSN: 1897-4317
ISSN: 1895-5770
Gastroenterology Review/Przegląd Gastroenterologiczny
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
2/2010
vol. 5
 
Share:
Share:
abstract:
Review paper

Profits from biological treatment in inflammatory bowel disease patients

Agnieszka Dobrowolska-Zachwieja
,
Ludwika Jakubowska-Burek

Przegląd Gastroenterologiczny 2010; 5 (2): 68–76
Online publish date: 2010/05/12
View full text Get citation
 
PlumX metrics:
Colitis ulcerosa (CU) and Crohn disease (CD) belong to inflammatory bowel diseases (IBD). Characteristic for the disease are remissions and recurrences, when the pharmacological treatment is necessery. Unfortunatelly, although there are instructions and the aims of treatment are precised, optimal therapeutic procedures are not well defined. Conventional methods are not effective in the most serious cases. In this paper standard therapuetic procedures and newest trends in treatment of IBD are described.
keywords:

inflammatory bowel diseases, biological treatment, therapeutic procedures in inflammatory bowel diseases

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.